{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T17:09:04Z","timestamp":1795108144071,"version":"4.10.3"},"reference-count":30,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acta Obstet Gynecol Scand"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Gestational diabetes mellitus (GDM) is defined by one or more abnormal values in an oral glucose tolerance test (OGTT). The significance\/importance of the number of abnormal values in relation to adverse perinatal and neonatal outcomes is unclear. We assessed the association of these outcomes with the number of abnormal glucose values in a 2\u2010h 75\u2009g OGTT in a large register\u2010based cohort.<\/jats:p><\/jats:sec><jats:sec><jats:title>Material and Methods<\/jats:title><jats:p>This sub\u2010study of the Finnish Gestational Diabetes Study was based on the Finnish Medical Birth Register 2009 supplemented with OGTT laboratory data of 4869 pregnant women from six Finnish hospitals. The diagnostic cut\u2010offs in OGTT according to the Finnish guidelines for plasma samples were\u2009\u22655.3\u2009mmol\/L (fasting), \u226510.0\u2009mmol\/L 1\u2009h or \u22658.6\u2009mmol\/L 2\u2009h after the glucose load. As per the guidelines, women with one or several abnormal OGTT values received diet and lifestyle counseling in the primary care, self\u2010monitored their glucose values and received pharmacological therapy as needed. Women with GDM were categorized according to the number of abnormal glucose values. The primary outcomes, composites of adverse perinatal (pre\u2010eclampsia, preterm delivery, macrosomia or primary cesarean section) and neonatal outcomes (birth trauma, neonatal hypoglycemia, hyperbilirubinemia or stillbirth\/perinatal mortality), were analyzed by logistic regression adjusted for maternal age, pre\u2010pregnancy body mass index, parity, socio\u2010economic status and smoking.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of all the women, 877 (18.0%) had one, 278 (5.7%) two and 79 (1.6%) three abnormal OGTT values, while 3635 (74.7%) women were normoglycemic. Women with at least two abnormal OGTT values had higher proportions of adverse perinatal composite (35.0% vs. 27.5%, adjusted odds ratio 1.36; 95% confidence interval 1.03\u20131.81) and neonatal composite outcomes (31.1% vs. 18.9%, adjusted odds ratio 1.88; 95% confidence interval 1.40\u20132.52) compared to women with one abnormal value. The risks of delivery induction and neonatal hypoglycemia were increased regardless of the number of abnormal values when compared with normoglycemic women.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The risk of adverse perinatal and neonatal outcomes is significantly higher in women with two or more abnormal OGTT values than in those with one abnormal value.<\/jats:p><\/jats:sec>","DOI":"10.1111\/aogs.14999","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T13:03:14Z","timestamp":1730293394000},"page":"130-138","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Perinatal and neonatal outcomes in gestational diabetes: The importance of the number of abnormal values in an oral glucose tolerance test"],"prefix":"10.1111","volume":"104","author":[{"given":"Sanna","family":"Etel\u00e4inen","sequence":"first","affiliation":[{"name":"Research Unit of Clinical Medicine, Medical Research Centre Oulu Oulu University Hospital and University of Oulu  Oulu Finland"},{"name":"Population Health Unit Finnish Institute for Health and Welfare  Helsinki and Oulu Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elina","family":"Keikkala","sequence":"additional","affiliation":[{"name":"Research Unit of Clinical Medicine, Medical Research Centre Oulu Oulu University Hospital and University of Oulu  Oulu Finland"},{"name":"Population Health Unit Finnish Institute for Health and Welfare  Helsinki and Oulu Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0005-9187","authenticated-orcid":false,"given":"Shilpa","family":"Lingaiah","sequence":"additional","affiliation":[{"name":"Research Unit of Clinical Medicine, Medical Research Centre Oulu Oulu University Hospital and University of Oulu  Oulu Finland"},{"name":"Population Health Unit Finnish Institute for Health and Welfare  Helsinki and Oulu Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matti","family":"Viljakainen","sequence":"additional","affiliation":[{"name":"Research Unit of Clinical Medicine, Medical Research Centre Oulu Oulu University Hospital and University of Oulu  Oulu Finland"},{"name":"Population Health Unit Finnish Institute for Health and Welfare  Helsinki and Oulu Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuija","family":"M\u00e4nnist\u00f6","sequence":"additional","affiliation":[{"name":"Northern Finland Laboratory Centre (NordLab), Department of Clinical Chemistry, Medical Research Center Oulu Oulu University Hospital and University of Oulu  Oulu Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneli","family":"Pouta","sequence":"additional","affiliation":[{"name":"Research Unit of Clinical Medicine, Medical Research Centre Oulu Oulu University Hospital and University of Oulu  Oulu Finland"},{"name":"Department of Government Services Finnish Institute for Health and Welfare  Helsinki Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risto","family":"Kaaja","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Institute of Clinical Medicine Turku University Hospital and University of Turku  Turku Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan G.","family":"Eriksson","sequence":"additional","affiliation":[{"name":"Department of General Practice and Primary Health Care, Helsinki University Hospital University of Helsinki  Helsinki Finland"},{"name":"Folkh\u00e4lsan Research Center  Helsinki Finland"},{"name":"Agency for Science, Technology and Research Singapore Institute for Clinical Sciences  Singapore Singapore"},{"name":"Department of Obstetrics and Gynecology and Human Potential Translational Research Programme, Yong Loo Lin School of Medicine National University of Singapore  Singapore Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3212-7826","authenticated-orcid":false,"given":"Hannele","family":"Laivuori","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology Tampere University Hospital  Tampere Finland"},{"name":"Center for Child, Adolescent and Maternal Health Research, Faculty of Medicine and Health Technology Tampere University  Tampere Finland"},{"name":"Department of Medical and Clinical Genetics Helsinki University Hospital and University of Helsinki  Helsinki Finland"},{"name":"Institute for Molecular Medicine Finland, Helsinki Institute of Life Science University of Helsinki  Helsinki Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Gissler","sequence":"additional","affiliation":[{"name":"Department of Knowledge Brokers Finnish Institute for Health and Welfare  Helsinki Finland"},{"name":"Department of Molecular Medicine and Surgery Karolinska Institute  Stockholm Sweden"},{"name":"Academic Primary Health Care Centre Region Stockholm  Stockholm Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eero","family":"Kajantie","sequence":"additional","affiliation":[{"name":"Research Unit of Clinical Medicine, Medical Research Centre Oulu Oulu University Hospital and University of Oulu  Oulu Finland"},{"name":"Population Health Unit Finnish Institute for Health and Welfare  Helsinki and Oulu Finland"},{"name":"Children's Hospital, Helsinki University Hospital University of Helsinki  Helsinki Finland"},{"name":"Department of Clinical and Molecular Medicine Norwegian University of Science and Technology  Trondheim Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marja","family":"V\u00e4\u00e4r\u00e4sm\u00e4ki","sequence":"additional","affiliation":[{"name":"Research Unit of Clinical Medicine, Medical Research Centre Oulu Oulu University Hospital and University of Oulu  Oulu Finland"},{"name":"Population Health Unit Finnish Institute for Health and Welfare  Helsinki and Oulu Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,10,30]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109050"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-0719"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0707943"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0020-7292(15)30033-3"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2013.10.012"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2016.04.040"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2006.01.028"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2017.01.025"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-1445"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000012920"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040296"},{"key":"e_1_2_12_13_1","unstructured":"Gestational diabetes.Current Care Guidelines. Working group set up by the Finnish Medical Society Duodecim the Medical Advisory Board of the Finnish Diabetes Association and the Finnish Gynecological Association. 2008. Finnish Medical Society Duodecim. Accessed 15 Mar 2024.www.kaypahoito.fi"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyaa039"},{"key":"e_1_2_12_15_1","unstructured":"Finnish Institute for Health and Welfare.Medical birth register: quality description 2018. Accessed 15 Mar 2024https:\/\/thl.fi\/en\/web\/thlfi\u2010en\/statistics\u2010and\u2010data\/data\u2010and\u2010services\/quality\u2010and\u2010statistical\u2010principles\/quality\u2010descriptions\/parturients\u2010delivers\u2010and\u2010newborns"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1080\/14639230110119234"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1177\/140349489502300113"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-S042"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.2007.S88"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0902430"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-017-4206-6"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.13764"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.3109\/07853890.2013.803739"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.2337\/diab.28.12.1039"},{"key":"e_1_2_12_25_1","first-page":"278","article-title":"Criteria for the oral glucose tolerance test in pregnancy","volume":"13","author":"O'Sullivan JB","year":"1964","journal-title":"Diabetes"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-021-01815-6"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2006.11.016"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-016-3927-2"},{"key":"e_1_2_12_29_1","article-title":"The prognostic value of the oral glucose tolerance test for future type\u20102 diabetes in nulliparous pregnant women testing negative for gestational diabetes","volume":"48","author":"Hiersch L","year":"2022","journal-title":"Diabetes Metab"},{"key":"e_1_2_12_30_1","first-page":"573","article-title":"Post\u2010challenge glycemia during pregnancy as a marker of future risk of type 2 diabetes: a prospective cohort study","volume":"31","author":"Hakkarainen H","year":"2015","journal-title":"Gynecol Endocrinol"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2016.1198764"}],"container-title":["Acta Obstetricia et Gynecologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/aogs.14999","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T10:34:29Z","timestamp":1735814069000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/aogs.14999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,30]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["10.1111\/aogs.14999"],"URL":"https:\/\/doi.org\/10.1111\/aogs.14999","archive":["Portico"],"relation":{},"ISSN":["0001-6349","1600-0412"],"issn-type":[{"value":"0001-6349","type":"print"},{"value":"1600-0412","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,30]]},"assertion":[{"value":"2024-05-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}